You have 9 free searches left this month | for more free features.

Velpatasvir

Showing 26 - 50 of 109

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Hepatitis C Virus Trial in New Zealand, United States (Velpatasvir)

Completed
  • Hepatitis C Virus
  • Velpatasvir
  • Miami, Florida
  • +4 more
Oct 20, 2020

Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir

Completed
  • Kidney Transplant
  • +2 more
  • Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
  • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
  • Columbus, Ohio
    Brenda Cuson
Jul 29, 2021

Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)

Completed
  • Hepatitis C
  • SOF/VEL for 6 weeks
  • SOF/VEL for 12 weeks
  • Baltimore, Maryland
  • +24 more
Nov 22, 2021

HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)

Completed
  • HCV Infection
  • Christchurch, New Zealand
    (unnamed)
Aug 17, 2020

Chronic Hepatitis C Virus Trial in Puerto Rico, United States (Velpatasvir, Placebo)

Completed
  • Chronic Hepatitis C Virus
  • Velpatasvir
  • Placebo
  • Costa Mesa, California
  • +9 more
Dec 11, 2020

Direct Acting Anti-Viral's In Chronic HCV Patients

Completed
  • Safety Issues
  • Faisalabad, Punjab, Pakistan
    Liver Center Faisalabad
Dec 10, 2020

Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

Recruiting
  • Chronic Hepatitis C
  • Chronic Hepatitis B
  • Tenofovir Alafenamide 25 MG
  • Sofosbuvir / Velpatasvir
  • Beijing, Beijing, China
    Peking University First Hospital
Aug 2, 2021

Hepatitis C Virus Infection Trial in Italy, Poland, United Kingdom (SOF/VEL/VOX)

Terminated
  • Hepatitis C Virus Infection
  • Firenze, Italy
  • +9 more
Sep 28, 2020

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

Terminated
  • Hepatitis C Virus Infection
  • Sofosbuvir (SOF)
  • +3 more
  • Phoenix, Arizona
  • +50 more
Jan 25, 2023

Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

Completed
  • Hepatitis C
  • Cryoglobulinemia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 23, 2020

Hepatitis C Virus Infection Trial in Worldwide (SOF/VEL)

Completed
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +26 more
Oct 5, 2020

Hepatitis C Trial in Boston (Sofosbuvir/Velpatasvir Treatment for 14 days)

Withdrawn
  • Hepatitis C
  • Sofosbuvir/Velpatasvir Treatment for 14 days
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 16, 2020

End Stage Renal Disease Trial in United States (Epclusa)

Recruiting
  • End Stage Renal Disease
  • Birmingham, Alabama
  • +8 more
Feb 1, 2023

Hepatitis C Virus Infection Trial in France, United States (SOF/VEL, RBV)

Completed
  • Hepatitis C Virus Infection
  • Tampa, Florida
  • +11 more
Feb 18, 2020

HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence Trial in Regina (Genvoya, Epclusa, Biktarvy)

Unknown status
  • HIV-1-infection
  • +8 more
  • Regina, Saskatchewan, Canada
    Saskatchewan Health Authority
Dec 23, 2019

Heart Failure Trial in Los Angeles, Durham, Dallas (Epclusa)

Recruiting
  • Heart Failure
  • Los Angeles, California
  • +2 more
Jan 27, 2022

Chronic Hepatitis C Trial in Worldwide (SOF/VEL)

Completed
  • Chronic Hepatitis C
  • Adelaide, South Australia, Australia
  • +21 more
Feb 18, 2020

Hepatitis C Trial in Karachi (undefined)

Recruiting
  • Hepatitis C
  • Karachi, Sindh, Pakistan
    Clinical trials unit
Feb 10, 2022

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

Recruiting
  • Hepatitis C
    • Istanbul, Turkey
      Cerrahpasa Medical Faculty
    Aug 26, 2023

    Eliminating HCV Infection Among PWUD

    Recruiting
    • Hepatitis C, Chronic
    • Drug Use
    • Vancouver, British Columbia, Canada
      Vancouver Infectious Diseases Centre
    Jul 22, 2022

    HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))

    Not yet recruiting
    • HCV
    • Prophylaxis (P2W)
    • Transmit and Treat (T&T)
    • New Orleans, Louisiana
    • +5 more
    Dec 6, 2022